Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Readings
Brown, R. G., Lacomblez, L., Lanwehmeyer, B. G., Bak, T., Uttner, I., Dubois, B., Agid, Y., Ludolph, A., Bensimon, G., Payan, C., Leigh, N. P., & NIPPS Study Group. (2010). Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain, 133, 2382–2393.
Colosimo, C., Bak, T. H., Bollogna, M., & Berardelli, A. (2014). Fifty years of progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry, 85, 936–942.
Eschlböck, S., Krismer, F., & Wenning, G. K. (2016). Interventional trials in atypical parkinsonism. Parkinsonism and Related Disorders, 22(Suppl 1), S82–S92.
Gerstenecker, A. (2017). The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration. Archives of Clinical Neuropsychology 32(7), 861–875.
Gerstenecker, A., Duff, K., Mast, B., Litvan, I., & ENGENE-PSP Study Group. (2013a). Behavioral abnormalities in progressive supranuclear palsy. Psychiatry Research, 210, 1205–1210.
Gerstenecker, A., Mast, B., Duff, K., Ferman, T. J., Litvan, I., & ENGENE-PSP Study Group. (2013b). Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Archives of Clinical Neuropsychology, 28, 104–113.
Lee, Y. E., Williams, D. R., & Anderson, J. F. (2016). Frontal deficits differentiate progressive supranuclear palsy from Parkinson’s disease. Journal of Neuropsychology, 10, 1–14.
Litvan, I., Paulsen, J. S., Mega, M. S., & Cummings, J. L. (1998). Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Archives of Neurology, 55, 1313–1319.
Respondek, G., Stamelou, M., Kurz, C., Ferguson, L. W., Rajput, A., Chiu, W. Z., et al. (2014). The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Movement Disorders, 29, 1758–1766.
Schrag, A., Selai, C., Davis, J., Lees, A. J., Jahanshahi, M., & Quinn, N. (2003). Health-related quality of life in patients with progressive supranuclear palsy. Movement Disorders, 18, 1464–1469.
Tröster, A. I. (Ed.). (2015). Clinical neuropsychology and cognitive neurology of Parkinson’s disease and other movement disorders. New York: Oxford University Press.
Tröster, A. I., & Garrett, R. (2018). Parkinson’s disease and other movement disorders. In J. E. Morgan & J. H. Ricker (Eds.), Textbook of clinical neuropsychology (2nd ed.) (pp.507-559). New York: Routledge.
Williams, D. R., de Silva, R., Paviour, D. C., Pittman, A., Watt, H. C., Kilford, L., et al. (2005). Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain, 128, 1247–1258.
Zampieri, C., & Di Fabio, R. P. (2006). Progressive supranuclear palsy: Disease profile and rehabilitation strategies. Physical Therapy, 86, 870–880.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Tröster, A.I. (2018). Progressive Supranuclear Palsy. In: Kreutzer, J.S., DeLuca, J., Caplan, B. (eds) Encyclopedia of Clinical Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-57111-9_522
Download citation
DOI: https://doi.org/10.1007/978-3-319-57111-9_522
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57110-2
Online ISBN: 978-3-319-57111-9
eBook Packages: Behavioral Science and PsychologyReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences